All blog posts
Total 15 results for
Showing 12 out of 15 results
23 December 2025
Mixing it up: The end of the line for patent term extensions for formulation patents in Australia
15 December 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
09 December 2025
Preserving the status quo: Boehringer Ingelheim awarded interim injunction
02 December 2025
UPC holds CE marking approval is evidence of imminent infringement and starts the clock running where considering any (unreasonable) delay in a PI application
03 September 2025
Herbert Smith Freehills Kramer comments for LSIPR on small molecule litigation in the UPC
31 July 2025
EU Regulatory Reform for Medicinal Products: Bolar exemption
30 July 2025
When will modifying a chemical scaffold be inventive? The UK Court of Appeal opines in the Xtandi case
21 July 2025
Trends emerging as the UPC enters its third year
19 May 2025
IP licensing: take care when considering market practices
13 May 2025
EU Regulatory Reform for Medicinal Products: Changes to MAs, supply, and transparency
30 April 2025
EU Regulatory Reform for Medicinal Products: Review of new regulatory exclusivities
25 February 2025
CJEU clears the way for single courts determining infringement actions in multiple jurisdictions without invalidity counterclaims interfering with the process (BSH Hausgerate v Electrolux)
Showing 12 out of 15 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Herbert Smith Freehills Kramer Kewei Joint Operation, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London